Child Health Evaluation and Research Unit, University of Michigan, 300 N Ingalls, Ann Arbor, MI 48109-5456, USA.
Matern Child Health J. 2013 Sep;17(7):1185-90. doi: 10.1007/s10995-012-1104-x.
Our objective was to describe the experiences of obstetricians during the 2009-2010 H1N1 vaccination campaign in order to identify possible improvements for future pandemic situations. We conducted a cross-sectional mail survey of a national random sample of 4,000 obstetricians, fielded in Summer 2010. Survey items included availability, recommendation, and patient acceptance of H1N1 vaccine; prioritization of H1N1 vaccine when supply was limited; problems with H1N1 vaccination; and likelihood of providing vaccine during a future influenza pandemic. Response rate was 66 %. Obstetricians strongly recommended H1N1 vaccine during the second (85 %) and third (86 %) trimesters, and less often during the first trimester (71 %) or the immediate postpartum period (76 %); patient preferences followed a similar pattern. H1N1 vaccine was typically available in outpatient obstetrics clinics (80 %). Overall vaccine supply was a major problem for 30 % of obstetricians, but few rated lack of thimerosal-free vaccine as a major problem (12 %). Over half of obstetricians had no major problems with the H1N1 vaccine campaign. Based on this experience, 74 % would be "very likely" and 12 % "likely" to provide vaccine in the event of a future influenza pandemic. Most obstetricians strongly recommended H1N1 vaccine, had few logistical problems beyond limited vaccine supply, and are willing to vaccinate in a future pandemic. Addressing concerns about first-trimester vaccination, developing guidance for prioritization of vaccine in the event of severe supply constraints, and continued facilitation of the logistical aspects of vaccination should be emphasized in future influenza pandemics.
我们的目的是描述妇产科医生在 2009-2010 年 H1N1 疫苗接种运动期间的经验,以便为未来的大流行情况确定可能的改进措施。我们对全国范围内随机抽取的 4000 名妇产科医生进行了横断面邮件调查,调查于 2010 年夏季进行。调查项目包括 H1N1 疫苗的可获得性、推荐和患者接受情况;供应有限时 H1N1 疫苗的优先排序;H1N1 疫苗接种存在的问题;以及在未来流感大流行期间提供疫苗的可能性。回复率为 66%。妇产科医生强烈建议在妊娠第二(85%)和第三(86%)期接种 H1N1 疫苗,而在妊娠第一期(71%)或产后立即(76%)接种疫苗的建议较少;患者的偏好也遵循类似的模式。H1N1 疫苗通常在妇产科门诊诊所(80%)中提供。对 30%的妇产科医生来说,疫苗的总体供应是一个主要问题,但很少有人认为缺乏无硫柳汞疫苗是一个主要问题(12%)。超过一半的妇产科医生在 H1N1 疫苗接种运动中没有遇到重大问题。根据这一经验,74%的人表示“非常有可能”,12%的人表示“可能”在未来发生流感大流行时提供疫苗。大多数妇产科医生强烈建议接种 H1N1 疫苗,除了疫苗供应有限之外,他们在后勤方面几乎没有遇到重大问题,并且愿意在未来的大流行中接种疫苗。在未来的流感大流行中,应强调解决对妊娠早期接种疫苗的担忧、制定在供应严重受限的情况下疫苗优先排序的指南,并继续促进疫苗接种的后勤方面。